Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study.

Key Points

• This research aims to understand parent preferences regarding the safety and effectiveness of treatments for pediatric inflammatory bowel disease (IBD).
• Conducted a multicenter study across Canada
• Surveyed parents of children with IBD regarding their treatment preferences
• Analyzed responses to determine valued aspects of therapies
• Parents prioritize safety as equally important to effectiveness in treatment choices
• Recognition of parent preferences may enhance shared decision-making
• Identified novel therapies like FMT are important in discussions about treatment options